The Shilla H&R redefines premium travel for tourists from Greater China through its signature ...

Apple (NASDAQ: AAPL) used to be the most valuable company in the world. It used to be the undisputed bellwether of technology ...

LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.

A 6.8% sales decline and 7.5% decline in volume in North America during the second quarter of fiscal 2025 has prompted Oatly ...

Submission of NDA for LNZ100 in China by CORXEL Pharmaceuticals results in achievement of first milestone due to LENZ under the Development and Commercialization Agreement ...

The primary focus for investors today is the resumption of trade talks between Washington and Beijing, aimed at resolving ...

LENZ Therapeutics (NASDAQ:LENZ) said Monday that CORXEL Pharmaceuticals has submitted the new drug application for LNZ100 to the Center for Drug Evaluation of the National Medical Products ...

The 2025 World Artificial Intelligence Conference (WAIC), held from July 26 to 28 in Shanghai, brought together representatives from around the world to explore avenues for the inclusive growth of ...

China's neighborhood security environment is not a mere patchwork of individual nations or subregions, but rather a complex, ...

This trend presents a strategic challenge for traditional powers. If they improve their offers to retain influence, they ...

Trump is targeting China's transshipments through Southeast Asia. But can tariffs and trade agreements really curb China's ...